Price loading...

Myelodysplastic Syndrome: From Diagnosis to Treatment (Recent Advances in Hematology Research)

Haematology

Price data last checked 108 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

In this compilation, the authors review the biological aspects of myelodysplastic syndrome disease, diagnosis, and treatment, as well as innovations involving genetics and new treatment perspectives. Myelodysplastic syndromes are a heterogeneous group of clonal haematopoietic stem cells disorders characterized by dysplasia, as well as peripheral blood cytopenias with a hypercellular marrow and ineffective hematopoiesis. Myelodysplastic syndromes are frequently associated with acute and chronic inflammation, and autoimmune disorders such as: rheumatoid arthritis, bowel disease, diverse types of vasculitis, autoimmune anemias, several rheumatic and skin disorders, and certain thyroid disorders. Spliceosome mutations are the most frequent mutations found in blood and bone marrow cells of myelodysplastic syndromes patients. As such, the authors explore the four predominant splicing factor genes: SF3B1, SFRS2, U2AF1, ZRSR2. Subsequently, this collection discusses the CSNK1A1 gene in the context of myelodysplastic syndromes. It is located at 5q32 within the deleted region, which encodes for casein kinase 1α (CK1α). CK1α is a component of a multiprotein β-catenin destruction complex that regulates Wnt/β-catenin and p53 pathways. The concluding study focuses on the mutations in epigenetic modifiers occur which myelodysplastic syndromes and drive this disease, such as: DNA methylation, histone acetylation, and RNA interference that alters gene expression.

Product Specifications

Format: hardcover
ASIN: 1536179973
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Haematology
Domain: Amazon UK
Release Date: 22 July 2020
Listed Since: 09 June 2020

Barcode

No barcode data available

Myelodysplastic Syndrome: From Diagnosis to Treatment (Recent Advances in Hematology Research)

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Hematologic Malignancies: An Overview - Hematology Research

Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)

Myelodysplastic Syndromes: Pathobiology and Clinical Management: 36 (Basic and Clinical Oncology)

MYELODYSPLASTIC SYNDROMES: From Pathogenesis to Diagnosis & Therapy (Recent Advances in Hematology Research)

The Myelodysplastic Syndromes

Bone Marrow Failure (Pediatric Oncology)

Preleukemia

Normal and Malignant Hematopoieses: New Advances - Proceedings of the Sixth Pezcoller Symposium Held in Rovereto, Italy, June 29-July 1, 1994: v. 6

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)

Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America (Volume 34-2) (The Clinics: Internal Medicine, Volume 34-2)

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

Bone Marrow Failure, An Issue of Hematology/Oncology Clinics of North America (Volume 32-4) (The Clinics: Internal Medicine, Volume 32-4)

Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)

Burkitt Lymphoma: Updates in Etiology, Symptoms, Molecular Genetics and Treatment Options

The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America (Volume 31-4) (The Clinics: Internal Medicine, Volume 31-4)

Hematopoiesis - Biochemical, Cellular, and Genomic Perspectives

Molecular Hematopathology: An Integrated Case-Based Approach

Myeloma Bone Disease (Current Clinical Oncology)

Managing Myeloproliferative Neoplasms: A Case-Based Approach